Latest Articles

Publication Date
Case Report: Long-term maintenance of GnRH-a combined with dienogest for thoracic endometriosis syndrome.

Thoracic endometriosis syndrome is a rare form of endometriosis in which endometrial tissue is thought to migrate to the lungs and, with the onset of menstruation, the ectopic foci bleed, …

Published: Oct. 27, 2025, midnight
Shrutika Arjun shares her surgery journey and recovery after endometriosis treatment: I'm advised to take a 45-day break - MSN

Shrutika Arjun shares her surgery journey and recovery after endometriosis treatment: I'm advised to take a 45-day break MSN

Published: Oct. 25, 2025, 7:03 a.m.
Ferroptosis in the Ovarian Follicular Microenvironment: A Redox-Dependent Cell Death Pathway with Emerging Roles in PCOS, Oocyte Quality, and IVF Outcomes.

Ferroptosis is a novel kind of regulated cell death that occurs when redox equilibrium is disrupted, leading to iron-dependent lipid peroxidation. Ferroptosis is defined by the buildup of deleterious lipid …

Published: Oct. 25, 2025, midnight
Bayer gets FDA approval for hot flash treatment - Endpoints News

Bayer gets FDA approval for hot flash treatment Endpoints News

Published: Oct. 24, 2025, 8:16 p.m.
Treatment paradigm for recurrent endometriosis shifts from surgery to medication - koreabiomed.com

Treatment paradigm for recurrent endometriosis shifts from surgery to medication koreabiomed.com

Published: Oct. 24, 2025, 8:01 a.m.
Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Dienogest (DNG) is widely used to manage endometriosis-associated pain; however, long-term data comparing low and standard doses are limited. Therefore, this study aimed to evaluate the efficacy and safety of …

Published: Oct. 24, 2025, midnight
Effects of hormonal treatment on the expression of collagen type I, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinases-1 in endometriosis.

Endometriosis is an estrogen-dependent disease, and hormonal treatment is the most common treatment. Both deep infiltrating endometriosis (DIE) and ovarian endometrioma (OV) are characterized by dense surrounding fibrotic tissue. However, …

Published: Oct. 24, 2025, midnight
HMGB-1 Increases Proinflammatory Reaction via TLR4 in Human Granulosa Cells of Endometriosis.

Background/Objectives: Oxidative stress is a critical factor in the development and progression of endometriosis. Granulosa cells, which reside near oocytes in follicles, exhibit steroidogenic activity, and, consequently, influence oocyte quality. …

Published: Oct. 24, 2025, midnight
Targeting Steroid Receptor Coactivators for the Treatment of Benign Female Reproductive Disorders.

Steroid receptor coactivators (SRCs) are master regulators of nuclear receptor signaling and play essential roles in female reproductive physiology. By integrating steroid hormone signaling with growth factors and metabolic pathways, …

Published: Oct. 23, 2025, midnight
ASCO Reading Room | Here's How the Treatment Landscape for Gynecologic Cancers Is About to Change - MedPage Today

ASCO Reading Room | Here's How the Treatment Landscape for Gynecologic Cancers Is About to Change MedPage Today

Published: Oct. 22, 2025, 2:54 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!